Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection (PHINDER)

NCT05776225 is registered in ClinicalTrials.gov with United Therapeutics as lead sponsor.

NCT NCT05776225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05776225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection (PHINDER)
Lead sponsor
United Therapeutics
Phase
Observational
Overall status
Completed
Start date
August 11, 2023
Completion date
April 29, 2026
Enrollment
314 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, pulmonary hypertension